Witherspoon Charles 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Mar 1, 2024
Insider Transaction Report
Form 4
Witherspoon Charles
VP & Treasurer
Transactions
- Exercise/Conversion
Common Stock
2024-02-28$102.51/sh+2,019$206,968→ 3,998.091 total - Sale
Common Stock
2024-02-28$358.62/sh−2,019$724,061→ 1,979.091 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-02-28−2,019→ 529 totalExercise: $102.51From: 2020-02-19Exp: 2029-02-19→ Stock Options (Right to Buy) (2,019 underlying)
Footnotes (1)
- [F1]This award vests in four equal annual installments beginning on February 19, 2020.